Clinical Trial Update: Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Impact on Quality of Life

View source ↗

Summary

This trial update reports on long-term chemotherapy-induced peripheral neuropathy and quality of life in colon cancer patients treated with neoadjuvant FOLFOX.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: P. Herzen Moscow Oncology Research Institute | Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN) | Status: COMPLETED